AtheroGenics Reports First Quarter 2007 Financial Results

April 26, 2007 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

ATLANTA, GA -- (MARKET WIRE) -- April 26, 2007 -- AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today reported financial results for the first quarter ended March 31, 2007.

Twitter
LinkedIn
Facebook
Email
Print

Earnings